Investors & Media

Investors & Media

Welcome to our investor page

We aspire to individualize cancer medicine

BioNTech was founded in 2008 on the understanding that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized. To translate this idea into reality, we have combined ground-breaking research with cutting-edge technologies to develop pioneering therapeutics for cancer and beyond. As we prove the value of our approach in the clinic, we will continue to build the partnerships, manufacturing and team required to bring individualized treatments to patients worldwide. From our roots in Mainz, Germany, we are driven to become the leading global biotechnology company for individualized cancer medicine.


Stock Quote

Mar 30, 2020 /

Copyright West LLC. Minimum 15 minutes delayed.

Upcoming Events

March 31, 2020

Full Year 2019 results

May 12, 2020

First Quarter 2020 update

May 15, 2020

BioNTech SE Annual General Meeting

Mainz, Germany

Upcoming events (more)

Press Releases

23 March 2020

BioNTech to report full year financial results for 2019 and provide corporate ..

17 March 2020

Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine

16 March 2020

BioNTech and Fosun Pharma form COVID-19 vaccine strategic alliance in China

Press releases (more)